Global Pharmaceuticals & Biotech Most Popular Stocks

Day One Biopharmaceuticals

Market Cap: US$684.2m

A commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States.

TaiMed Biologics

Market Cap: NT$20.8b

A biotechnology company, develops, manufactures, and commercializes drugs for the treatment and prevention of infectious diseases.

Obio Technology (Shanghai)

Market Cap: CN¥4.8b

A biotechnology company, focuses on the development of gene therapy vectors in China.

Thalys Medical Technology Group

Market Cap: CN¥4.8b

Provides intensive operation services of medical inspection in China.

Sinotherapeutics

Market Cap: CN¥4.8b

A specialty pharmaceutical company, develops generic and formulation products in China.

Elite Pharmaceuticals

Market Cap: US$670.8m

A specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals.

Tyra Biosciences

Market Cap: US$668.3m

A clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States.

Shanghai New World

Market Cap: CN¥4.8b

Owns and operates department stores in China.

Ningbo Menovo Pharmaceutical

Market Cap: CN¥4.7b

Research, develops, produces, and sells pharmaceutical products.

Middle East Pharmaceutical Industries

Market Cap: ر.س2.5b

Engages in the research, development, manufacture, and marketing of generic medicines and pharmaceutical preparations in the Kingdom of Saudi Arabia and internationally.

Zhejiang Starry PharmaceuticalLtd

Market Cap: CN¥4.7b

Engages in the research and development, production, and sale of X-CT non-ionic contrast agents and fluoroquinolones drugs and intermediates in China and internationally.

Zentiva

Market Cap: RON 3.2b

Engages in the production and marketing of preparations and medicines for human use in Romania and internationally.

Gyre Therapeutics

Market Cap: US$662.1m

A pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis.

EirGenix

Market Cap: NT$20.2b

Operates as a contract development and manufacturing company in Taiwan and internationally.

PharmaResources (Shanghai)

Market Cap: CN¥4.7b

Operates as a CRO, CDMO, and CMO service provider of drug discovery in China.

MeiraGTx Holdings

Market Cap: US$658.9m

A clinical stage genetics medicines company, focusing on developing treatments for patients with serious diseases.

PEPTONIC medical

Market Cap: €560.2m

A pharmaceutical company, researches, develops, and sells medical treatments and lifestyle products in the field of women's health.

Pulike Biological Engineering

Market Cap: CN¥4.7b

Engages in the research, development, production, and sale of veterinary biological products, chemical drugs, and traditional Chinese veterinary drugs.

Viva Biotech Holdings

Market Cap: HK$5.1b

An investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide.

Tempo Scan Pacific

Market Cap: Rp10.9t

Engages in the pharmaceuticals, personal care and cosmetics, and distribution services businesses in Indonesia and internationally.

Terns Pharmaceuticals

Market Cap: US$651.1m

A clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity.

Beijing Kawin Technology Share-Holding

Market Cap: CN¥4.6b

A biopharmaceutical company, provides treatment solutions for viral and immune diseases in China.

Beijing Luzhu Biotechnology

Market Cap: HK$5.0b

A biotechnology company, focuses on the research and development, production, and sale of human vaccines and therapeutic biologics to prevent and control infectious diseases, and treat cancer and autoimmune diseases in Mainland China.

Keros Therapeutics

Market Cap: US$641.7m

A clinical-stage biopharmaceutical company, develops and commercializes novel therapeutics for patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta family of proteins in the United States.

Daewoong

Market Cap: ₩901.6b

Engages in the manufacture and sale of pharmaceuticals in South Korea.

Palvella Therapeutics

Market Cap: US$638.0m

A clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat patients serious and rare genetic skin diseases.

Chongqing Lummy Pharmaceutical

Market Cap: CN¥4.6b

Engages in the research and development, manufacture, and sale of pharmaceutical products in China.

Yabao Pharmaceutical Group

Market Cap: CN¥4.6b

Researches, develops, manufactures, and sells Chinese and Western medicines, and pharmaceutical packaging materials in China and internationally.

Supriya Lifescience

Market Cap: ₹56.5b

Engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide.

Nurix Therapeutics

Market Cap: US$636.8m

A clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and antibody therapies for the treatment of cancer, inflammatory conditions, and other diseases.

Aquestive Therapeutics

Market Cap: US$636.3m

Operates as a pharmaceutical company in the United States and internationally.

Berry GenomicsLtd

Market Cap: CN¥4.5b

A genomics and life science company, develops and commercializes of genetic test technologies in clinical applications in China.

TTY Biopharm

Market Cap: NT$19.3b

Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally.

SNDL

Market Cap: US$633.1m

Engages in the production, distribution, and sale of cannabis products for the adult-use market in Canada.

Gossamer Bio

Market Cap: US$632.1m

A clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States.

ChengDa Pharmaceuticals

Market Cap: CN¥4.5b

Engages in the research and development, production, and sale of pharmaceutical intermediates, chemical ingredients, and food and feed additives in China and internationally.